Literature DB >> 11774793

p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines.

J L Adams1, A M Badger, S Kumar, J C Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11774793     DOI: 10.1016/s0079-6468(08)70091-2

Source DB:  PubMed          Journal:  Prog Med Chem        ISSN: 0079-6468


× No keyword cloud information.
  34 in total

Review 1.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 2.  Unique MAP Kinase binding sites.

Authors:  Radha Akella; Thomas M Moon; Elizabeth J Goldsmith
Journal:  Biochim Biophys Acta       Date:  2007-11-19

3.  Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.

Authors:  Wanli You; Chia-En A Chang
Journal:  J Chem Inf Model       Date:  2018-04-16       Impact factor: 4.956

4.  Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.

Authors:  Ashley R Kochanek; Eugene Y Fukudome; Yongqing Li; Eleanor J Smith; Baoling Liu; George C Velmahos; Marc deMoya; David King; Hasan B Alam
Journal:  J Surg Res       Date:  2011-07-05       Impact factor: 2.192

5.  Salvianolic acid A attenuates kidney injury and inflammation by inhibiting NF-κB and p38 MAPK signaling pathways in 5/6 nephrectomized rats.

Authors:  Hong-Feng Zhang; Yan-Li Wang; Cheng Gao; Yan-Ting Gu; Jian Huang; Jin-Hui Wang; Jia-Hong Wang; Zhou Zhang
Journal:  Acta Pharmacol Sin       Date:  2018-05-23       Impact factor: 6.150

Review 6.  p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD.

Authors:  Audreesh Banerjee; Cynthia Koziol-White; Reynold Panettieri
Journal:  Curr Opin Pharmacol       Date:  2012-02-24       Impact factor: 5.547

7.  Renoprotective effects of angiotensin receptor blocker and stem cells in acute kidney injury: Involvement of inflammatory and apoptotic markers.

Authors:  Iman O Sherif; Laila A Al-Mutabagani; Anwar M Alnakhli; Mohamed A Sobh; Hoda E Mohammed
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-29

8.  LPS-induced MCP-1 expression in human microvascular endothelial cells is mediated by the tyrosine kinase, Pyk2 via the p38 MAPK/NF-kappaB-dependent pathway.

Authors:  Appakkudal R Anand; Ritu Bradley; Ramesh K Ganju
Journal:  Mol Immunol       Date:  2008-10-26       Impact factor: 4.407

9.  Development of a HTRF kinase assay for determination of Syk activity.

Authors:  Christopher Harbert; Jeannette Marshall; Sharon Soh; Krista Steger
Journal:  Curr Chem Genomics       Date:  2008-02-25

10.  Anticytokine therapy for periodontal diseases: Where are we now?

Authors:  Yogesh Prakash Waykole; S S Doiphode; P S Rakhewar; Maya Mhaske
Journal:  J Indian Soc Periodontol       Date:  2009-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.